More people are accessing medicinal cannabis than ever expected, or the health system was designed for. And we’re failing patients.
Articles on Medicines regulation
Displaying all articles
Medicinal cannabis scripts are rising and reports of side effects are likely an underestimate. Here’s what we know about the risks.
The latest announcement doesn’t tighten existing prescribing or marketing rules for medicinal cannabis. It just reminds health professionals what the rules are.
Relying on donor funding means that the funder ultimately determines the health priorities. This is one reason why many programmes in Africa focus on a single disease such as HIV.
We will struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
New Zealand has entered several international agreements to access COVID-19 vaccines, but it should also amend domestic patent law and regulatory processes to prevent delays and costly negotiations.
If the Therapeutic Goods Administration implements new proposals to regulate complementary medicines, you can be more confident they actually do what they say on the packet.
Classing e-cigarettes as quit smoking aids could help rebrand the tobacco industry as a legitimate player in health policy. Here’s why we should be concerned.
Thalidomide was developed in an era of widespread enthusiasm – but little critical attention – for pharmaceutical therapies.
Gamers around the world are snapping up a new device that promises to give them an edge on competitors by boosting their gaming focus. It is certainly easy to see the appeal of being able to improve your…
If I asked you to name some of the current threats to your health, “international trade law” probably wouldn’t be on the tip of your tongue. Yet trade agreements, and the way we negotiate them, can affect…
Millions of people use diclofenac, an over-the-counter painkiller, to relieve pain and inflammation caused by arthritis, backache and other conditions. But on Friday, the UK medicines regulator, the Medicines…
Top contributors
-
Senior Lecturer in Clinical Pharmacology, Queen Mary University of London
-
Assistant Professor, London School of Hygiene & Tropical Medicine
-
Professor of Practice in the School for the Future of Innovation in Society, Arizona State University
-
Postdoctoral Research Fellow in Ethics, University of Oxford
-
Associate Professor of Health Management and Policy and Global Public Health, University of Michigan
-
Health activist, Medreach Pty Ltd., Bond University
-
Adjunct Senior Lecturer, Centre for Primary Health Care and Equity, University of New South Wales, UNSW
-
Professor of Medicine, Monash University
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Professor in Global Health Infection and Immunity. and co-Director of the Global Health Academy, University of Edinburgh
-
Professor of Commercial Law, Te Herenga Waka — Victoria University of Wellington
-
Professor, Dalla Lana School of Public Health, University of Toronto
-
NHMRC Emerging Leadership Fellow, National Centre for Youth Substance Use Research, The University of Queensland
-
Senior Lecturer in Pharmacy, NHMRC Emerging Leadership Fellow, University of Sydney
-
Professor of Clinical Pharmacology, University of Sydney